Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

EnhancedTRAIL protein (DYKDDDDK Tag)

Origin: Human, Mouse Host: Escherichia coli (E. coli) Recombinant BCA, SDS
Catalog No. ABIN1305228
  • Target
    EnhancedTRAIL
    Protein Type
    Recombinant
    Origin
    Human, Mouse
    Source
    Escherichia coli (E. coli)
    Purification tag / Conjugate
    DYKDDDDK Tag
    Application
    Biochemical Assay (BCA), SDS-PAGE (SDS)
    Specificity
    Binds to human and mouse TRAIL receptors and human osteoprotegrin (OPG).
    Cross-Reactivity
    Human, Mouse (Murine)
    Components
    1 Set: 2x10μg TRAIL, Soluble (human) (rec.)3x50μg TNF Ligands Enhancer (
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Comment

    Source/Host: Produced in E. coli. A FLAG®-tag is fused at the N-terminus of the extracellular domain of human TRAIL (aa 95-281).Concentration: TRAIL: 0.1mg/ml after reconstitutionTNF Ligands Enhancer: 1mg/ml after reconstitutionPurity: >95% (SDS-PAGE)Formulation:Lyophilized. Contains PBS.Endotoxin Content:TRAIL: <0.01EU/μg purified protein (LAL test, Lonza).TNF Ligands Enhancer: <0.01EU/μg purified protein (LAL test, Lonza).Reconstitution:TRAIL: reconstitute with 100μl sterile water. PBS containing at least 0.1% BSA should be used for further dilutions.TNF Ligands Enhancer: reconstitute each vial with 50μl sterile water. PBS containing at least 0.1% BSA should be used for further dilutions.

    Restrictions
    For Research Use only
  • Concentration
    Lot specific
    Storage
    4 °C,-20 °C
    Storage Comment
    Short Term Storage: +4°C
    Long Term Storage: -20°C
    Stable for at least 6 months after receipt when stored at -20°C.
    Expiry Date
    6 months
  • Xiao, Yang, Asadi, Beguinot, Hao: "Tumor necrosis factor-related apoptosis-inducing ligand-induced death-inducing signaling complex and its modulation by c-FLIP and PED/PEA-15 in glioma cells." in: The Journal of biological chemistry, Vol. 277, Issue 28, pp. 25020-5, (2002) (PubMed).

    Déjosez, Ramp, Mahotka, Krieg, Walczak, Gabbert, Gerharz: "Sensitivity to TRAIL/APO-2L-mediated apoptosis in human renal cell carcinomas and its enhancement by topotecan." in: Cell death and differentiation, Vol. 7, Issue 11, pp. 1127-36, (2001) (PubMed).

    Benedict, Norris, Prigozy, Bodmer, Mahr, Garnett, Martinon, Tschopp, Gooding, Ware: "Three adenovirus E3 proteins cooperate to evade apoptosis by tumor necrosis factor-related apoptosis-inducing ligand receptor-1 and -2." in: The Journal of biological chemistry, Vol. 276, Issue 5, pp. 3270-8, (2001) (PubMed).

    Wang, Chun, Wong, Spencer, Lenardo: "Caspase-10 is an initiator caspase in death receptor signaling." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 98, Issue 24, pp. 13884-8, (2001) (PubMed).

    Liao, Ozawa, Friess, Zimmermann, Takayama, Reed, Kleeff, Büchler: "The anti-apoptotic protein BAG-3 is overexpressed in pancreatic cancer and induced by heat stress in pancreatic cancer cell lines." in: FEBS letters, Vol. 503, Issue 2-3, pp. 151-7, (2001) (PubMed).

  • Target
    EnhancedTRAIL
    Background
    Induces apoptosis in a concentration range of 5-50 ng/mL in the presence of 1 μg/mL of TNF Ligands Enhancer .
You are here:
Support